Does MannKind Finally Have What It Takes To Get Afrezza Inhaled Insulin Cleared By FDA?
This article was originally published in The Pink Sheet Daily
Executive Summary
Among other things, new FDA review will test whether the company has proven that data with an old device can be applied to the new inhaler the company plans to market. MannKind is not expecting an advisory committee meeting.